Canlyniadau Chwilio - Qiu‐Xu Teng

  • Dangos 1 - 11 canlyniadau o 11
Mireinio'r Canlyniadau
  1. 1
    Understanding and targeting resistance mechanisms in cancer

    Understanding and targeting resistance mechanisms in cancer gan Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, John N.D. Wurpel, Leli Zeng, Yihang Pan, Zhe‐Sheng Chen

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

    Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo gan Albert A. De Vera, Pranav Gupta, Zi‐Ning Lei, Dan Liao, Silpa Narayanan, Qiu‐Xu Teng, Sandra E. Reznik, Zhe‐Sheng Chen

    Cyhoeddwyd 2018
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

    Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells gan Wei Zhang, Yingfang Fan, Chao‐Yun Cai, Jing‐Quan Wang, Qiu‐Xu Teng, Zi‐Ning Lei, Leli Zeng, Pranav Gupta, Zhe‐Sheng Chen

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Signaling pathways and therapeutic interventions in gastric cancer

    Signaling pathways and therapeutic interventions in gastric cancer gan Zi‐Ning Lei, Qiu‐Xu Teng, Tian Qin, Wei Chen, Yuhao Xie, Kaiming Wu, Qianlin Zeng, Leli Zeng, Yihang Pan, Zhe‐Sheng Chen, Yulong He

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis

    The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis gan Zi‐Ning Lei, Qiu-Xu Teng, Jagadish Koya, Yangruiyu Liu, Zizhou Chen, Leli Zeng, Zhe‐Sheng Chen, Shuo Fang, Jinxiang Wang, Yuchen Liu, Yihang Pan

    Cyhoeddwyd 2024
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters

    VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters gan Ning Ji, Yuqi Yang, Chao‐Yun Cai, Zi‐Ning Lei, Jing‐Quan Wang, Pranav Gupta, Qiu‐Xu Teng, Zhe‐Sheng Chen, Dexin Kong, Dong‐Hua Yang

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells

    Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells gan Jing‐Quan Wang, Jonathan Y. Li, Qiu‐Xu Teng, Zi‐Ning Lei, Ning Ji, Qingbin Cui, Leli Zeng, Yihang Pan, Dong‐Hua Yang, Zhe‐Sheng Chen

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells

    Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells gan Weiguo Feng, Meng Zhang, Zhuo‐Xun Wu, Jing‐Quan Wang, Xing-Duo Dong, Yuqi Yang, Qiu‐Xu Teng, Xuan-Yu Chen, Qingbin Cui, Dong‐Hua Yang

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

    Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro gan Yuqi Yang, Ning Ji, Qiu‐Xu Teng, Chao‐Yun Cai, Jing‐Quan Wang, Zhuo‐Xun Wu, Zi‐Ning Lei, Sabrina Lusvarghi, Suresh V. Ambudkar, Zhe‐Sheng Chen

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance

    Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance gan Zhuo‐Xun Wu, Yuqi Yang, Qiu‐Xu Teng, Jing‐Quan Wang, Zi‐Ning Lei, Jing-Qiu Wang, Sabrina Lusvarghi, Suresh V. Ambudkar, Dong‐Hua Yang, Zhe‐Sheng Chen

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor

    Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor gan Saiqi Wang, Qiu‐Xu Teng, Shuai Wang, Zi‐Ning Lei, Huihui Hu, Huifang Lv, Beibei Chen, Jianzheng Wang, Xiaojing Shi, Weifeng Xu, Hong‐Min Liu, Xiaobing Chen, Zhe‐Sheng Chen, Bin Yu

    Cyhoeddwyd 2022
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: